psadt calculator

What is PSADT?

PSA Doubling Time (PSADT) is the estimated time it takes for prostate-specific antigen (PSA) to double. In prostate cancer follow-up, PSADT can provide useful context about how quickly PSA is changing over time. It is commonly discussed during surveillance after treatment, especially in settings like biochemical recurrence.

A shorter doubling time usually indicates a faster PSA rise, while a longer doubling time suggests a slower trend. However, PSADT is only one piece of the clinical picture. Your care team will also consider pathology, imaging, treatment history, testosterone status, symptoms, and overall health.

How this calculator works

This page uses the classic two-point PSADT equation:

PSADT = (Δt × ln(2)) / ln(PSA2 / PSA1)

• Δt = elapsed time between tests (in months)
• PSA1 = earlier PSA value
• PSA2 = latest PSA value

If PSA is unchanged, PSADT is effectively infinite (no doubling observed). If PSA decreases, doubling time is not applicable; in that case, this tool reports that PSA is falling and estimates a halving time for context.

How to use the PSADT calculator

Step-by-step

1. Enter your earlier PSA value and test date.
2. Enter your latest PSA value and test date.
3. Click Calculate PSADT.
4. Review the result in months and years, plus PSA velocity.

Tips for better accuracy

• Use values from the same lab when possible to reduce assay variability.
• Avoid using measurements taken too close together unless clinically necessary.
• Interpret trends across multiple tests, not a single jump.
• Discuss unexpected results with your oncologist or urologist.

Interpreting results (general educational ranges)

Interpretation ranges vary by guideline and clinical context, but many clinicians use practical categories for trend discussion:

• Less than 3 months: very rapid PSA rise
• 3 to 9 months: rapid rise
• 9 to 15 months: intermediate pace
• Greater than 15 months: slower rise

These bands are not diagnostic on their own. They are best viewed as a conversation starter for risk stratification and follow-up planning.

Why PSADT matters in prostate cancer follow-up

In post-treatment care, clinicians often monitor PSA kinetics to decide how urgently to image, whether to intensify surveillance, or when to discuss salvage or systemic options. A rapidly shortening PSADT may trigger closer follow-up, while a long and stable PSADT may support watchful observation in selected situations.

PSADT can also be compared with PSA velocity (change in ng/mL per year). While related, they are not interchangeable. Doubling time captures exponential behavior, whereas velocity is a linear rate.

Limitations you should know

• Biologic noise: PSA can fluctuate due to benign causes, inflammation, or laboratory variation.
• Two-point sensitivity: using only two values can overreact to outliers.
• Assay differences: switching laboratories can change baseline comparability.
• Clinical context: medications, prior treatment type, and testosterone levels all matter.

For medical decisions, your physician may calculate PSADT using more than two data points and more advanced modeling.

Example

Suppose PSA rises from 0.40 ng/mL to 0.80 ng/mL over about 12 months. Since the value doubled in roughly one year, PSADT is close to 12 months. If the same doubling happens over 6 months, PSADT is about 6 months and indicates a faster trend.

Frequently asked questions

Is a lower PSADT always worse?

Not always by itself, but shorter PSADT generally raises concern for faster disease activity. Interpretation depends on full clinical context.

Can I use this tool for diagnosis?

No. This is an educational calculator. It is not a diagnostic device and does not replace medical care.

Should I calculate using every PSA test?

You can, but trends are more meaningful when data are consistent and spaced appropriately. Your care team can help decide which values to use.

Medical disclaimer

This PSADT calculator is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your clinician before making any healthcare decisions.